Abbott Forward Looking Statements
Some statements in this news release may be forward-looking statements for the purposes of the Private Securities Litigation Reform Act of 1995. We caution that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated. Economic, competitive, governmental, technological and other factors that may affect Abbott's operations are discussed in Item 1A, "Risk Factors," to our Annual Report on Securities and Exchange Commission Form 10-K for the year ended Dec. 31, 2007, and in Item 1A, "Risk Factors," to Abbott's Quarterly Report on Securities and Exchange Commission Form 10-Q for the quarters ended June 30, 2008, and September 30, 2008, and are incorporated by reference. Statements regarding the prospects of AMO's business following acquisition by Abbott are qualified by AMO's forward-looking statement language appearing above. Abbott undertakes no obligation to release publicly any revisions to forward-looking statements as a result of subsequent events or developments.
About Advanced Medical Optics
Advanced Medical Optics is a global leader in ophthalmic care, comprised of three segments: cataract surgery/intraocular lens (IOL), laser vision correction and eye care products.
-- Headquarters: Santa Ana, Calif. -- Stock Symbol: NYSE: EYE -- Founded: 2002 (spin-off from Allergan) -- 2007 Sales: $1.09 billion -- Employees: 3,700
Copyright©2009 PR Newswire.
All rights reserved